BRIEF-Evolent Health Q3 Revenue USD 621.401 Million Vs. IBES Estimate USD 627.2 Million

Reuters
08 Nov 2024
BRIEF-Evolent Health Q3 Revenue USD 621.401 Million Vs. IBES Estimate USD 627.2 Million

Nov 07 (Reuters) - Evolent Health Q3 adjusted EBITDA USD 31.801 million vs. IBES estimate USD 62.7 million.

  • Q3 adjusted EBITDA margin 5.1%
  • Q3 net income USD -31.231 million vs. IBES estimate USD 40.6 million
  • outlook FY adjusted EBITDA USD 160-175 million
  • outlook Q4 adjusted EBITDA USD 22-37 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10